EW vs RAL · P/E 47, rev $1.39B vs rev $2.07B
Edwards Lifesciences Corp (EW) versus Ralliant Corporation Common Stock (RAL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Ralliant Corporation Common Stock (RAL) is a electronic components company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RAL revenue for 2025-12-31 was $2.07B. Net income was -$1.22B. Revenue was down 4.0% from 2024-12-31 to 2025-12-31. RAL currently screens at market cap $7.76B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RAL currently screens at market cap $7.76B.
Not investment advice. Open the EW and RAL stock pages for the full models.
Not investment advice.